Granules India Limited (GRANULES.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Granules India Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4057
First IPO Date
June 20, 2005
Key Executives
| Name | Title | Pay | Year Born |
| Chaitanya Tummala | Company Secretary & Compliance Officer | 7.89M | N/A |
| Mukesh Surana | Chief Financial Officer | 14.57M | 1981 |
| Priyanka Chigurupati | Head of Marketing & Executive Director | 23.68M | N/A |
| Harsha Chigurupati | Executive Director | 23.68M | 1983 |
| Krishna Prasad Chigurupati | Chairman & MD | 236.84M | 1954 |
| Ramraj Rangarajalu | President & Head of Formulations Operations | 0 | N/A |
| Sanjay Kumar | President & Chief Strategy Officer | 0 | N/A |
| N. Baskaran | President - Head API Manufacturing & Operations | 0 | N/A |
| Rajesh Kapoor | President & Global Head of Quality | 0 | N/A |
| V. Srinivas | Chief Technology Officer and Head of R&D | 0 | 1966 |
Description
Founded in 1984 and headquartered in Hyderabad, India, Granules India Limited operates as a key player in the pharmaceutical sector. The company is engaged in the manufacturing and global distribution of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs), intermediate compounds for drug formulation, and final dosage forms (FDFs). Its API portfolio addresses various therapeutic categories, such as antiviral medications, treatments for hypertension, antihistamines, anti-infectives, pain relief agents, anticoagulants, anti-fibrinolytic drugs, and platelet inhibitors. Additionally, Granules produces a variety of FDFs, encompassing tablets, caplets, and press-fit capsules, which are supplied in bulk, blister packs, and bottles. The firm also develops specialized products for oncology. Granules India Limited maintains a broad international presence, with its products reaching markets across India, North America, Europe, Latin America, Africa, and the Middle East.
